GSK Subsidiary Tesaro and AnaptysBio Update on Contract Litigation

GSK subsidiary Tesaro and AnaptysBio provided an update on ongoing litigation involving an anticipatory breach of contract claim. The Delaware Court of Chancery has granted a motion to dismiss, which may impact the legal proceedings between the companies.

By Arundhati Sarkar, SA News Editor · Seeking Alpha ·

GSK Subsidiary Tesaro and AnaptysBio Update on Contract Litigation

Tickers: $ANAB $GSK

Topics: contract dispute legal action litigation pharmaceutical industry subsidiary

Read the full article at Seeking Alpha

More World news